Yes, a local representative, known as a Korea Registration Holder (KRH), is required for foreign manufacturers seeking medical device registration in Korea. The KRH acts as a liaison with the Ministry of Food and Drug Safety (MFDS), ensuring compliance with local regulations... Read More
For Korean medical device registration, submit the following documents: application form, device description, technical documents, clinical data, risk analysis, quality management system certificate, labeling and packaging information, test reports, manufacturing information, and proof of conformity. Additionally, provide a Korean Good Manufacturing Practice... Read More
The classification system significantly impacts Korea’s medical device registration timelines by determining the level of regulatory scrutiny required. Higher-risk devices undergo more rigorous evaluation, leading to longer approval times. Conversely, lower-risk devices face streamlined processes, expediting registration. Accurate classification is crucial for... Read More
In Korea, medical devices are classified into four classes based on risk: Class I (low risk), Class II (moderate risk), Class III (high risk), and Class IV (highest risk). All classes require registration with the Ministry of Food and Drug Safety (MFDS)... Read More
The regulatory authority responsible for medical device registration in Korea is the Ministry of Food and Drug Safety (MFDS). The MFDS oversees the approval, regulation, and monitoring of medical devices to ensure safety and efficacy. Manufacturers must comply with MFDS guidelines and... Read More
A typical drug quality audit in Japan usually takes between two to five days, depending on the complexity and scope of the audit. This timeframe includes preparation, on-site inspection, and follow-up activities. The process ensures compliance with regulatory standards and involves thorough... Read More
Japan does not mandate mock audits or self-inspections before official drug quality audits. However, pharmaceutical companies often conduct them voluntarily to ensure compliance with Good Manufacturing Practices (GMP) and to identify potential issues. These proactive measures help companies prepare for official audits... Read More
In Japan, drug quality audits verify storage and transportation conditions through on-site inspections, reviewing temperature and humidity logs, and ensuring compliance with Good Distribution Practice (GDP) guidelines. Auditors assess facilities, equipment, and documentation to confirm that conditions meet regulatory standards, ensuring drug... Read More
Yes, environmental health and safety considerations are included in drug quality audits in Japan. Regulatory frameworks, such as the Good Manufacturing Practice (GMP) guidelines, emphasize environmental controls and safety measures to ensure product quality and compliance. These audits assess facilities’ adherence to... Read More
Japan manages confidential information from drug quality audits by adhering to strict regulatory frameworks, such as the Pharmaceuticals and Medical Devices Agency (PMDA) guidelines. These include secure data handling, limited access to sensitive information, and confidentiality agreements with stakeholders, ensuring compliance with... Read More